ArticlePharmaceutics2022

Pharmacokinetic-Pharmacometabolomic Approach in Early-Phase Clinical Trials: A Way Forward for Targeted Therapy in Type 2 Diabetes.

Khim Boon Tee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.